UTMD Formalizes $48.75M Self-Tender for 20% of Shares at $75
UTMD sits 38% above its 52-week low of $53.66.
Summary
UTMD formalizes its self-tender offer to buy back up to 650,000 shares at $75 each, a $48.75 million capital return representing roughly 20% of shares outstanding, with commencement September 22 and expiration fifteen business days later.
Key Events · Financing and Capital Events · UTMD
-
Self-Tender Offer Formalized
UTMD will repurchase up to 650,000 shares at $75.00 per share, a total outlay of approximately $48.75 million, representing roughly 20% of currently outstanding shares.
-
Premium Pricing vs. Historical Averages
The $75 offer price is 17% above the twelve-month average closing price and 21% above the two-year average, and sits just below the two-year intraday high of $75.75.
-
Tender Mechanics and Timeline
Offer commences September 22, 2026, and expires fifteen business days later (on or before October 7, 2026), unless extended. Odd-lot holders (fewer than 100 shares) receive priority, and the company may purchase more than 650,000 shares.
-
No Minimum Condition and No Board Recommendation
The offer is not conditioned on any minimum number of shares being tendered. The Board approved the offer but makes no recommendation to stockholders on whether to tender.
Analysis · UTMD · Industrial Applications And Services
A $48.75 million capital return is now on the table as Utah Medical Products moves forward with a self-tender offer to repurchase up to 650,000 shares at $75.00 per share. The offer commences September 22 and expires fifteen business days later, with odd-lot holders given priority and the company reserving the right to buy more than 650,000 shares. The $75 price represents a 17% premium to the twelve-month average closing price and a 21% premium to the two-year average, and sits just below the two-year intraday high of $75.75. Against a backdrop of declining revenue and reduced guidance, this tender is a deliberate return of capital to shareholders — an anti-dilutive move that concentrates ownership among continuing holders while giving those seeking liquidity an exit at a premium. The company's no-debt balance sheet and significant cash reserves make the $48.75 million outlay feasible without leverage. Notably, the board's decision to make no recommendation to stockholders leaves the decision entirely to shareholders, which is unusual for a self-tender and may reflect the board's view that the offer is fair but not necessarily compelling for all holders.
How filings like this one have moved
In the 30 days to Nov 1, 2026, 39.9% of the 1106 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.34%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UTMD was trading at $74.06 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $235.8M. The 52-week trading range was $53.66 to $75.75. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.